Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases
Condition: Tick-borne Encephalitis Intervention: Sponsor: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2022 Category: Research Source Type: clinical trials
Prevalence of Tick-borne Encephalitis (TBE) in the Pediatric Population Treated at the University Hospitals of Strasbourg and Characterization of Confirmed Pediatric Cases
Condition: Tick-borne Encephalitis, Alsace France Intervention: Sponsor: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2022 Category: Research Source Type: clinical trials
FDA Accepts for Priority Review Pfizer ’s Application for TicoVac™ (Tick-borne Encephalitis Vaccine)
February 23, 2021 - NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review the company’s Biologics License Application (BLA) for TicoVac™, its... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - February 23, 2021 Category: Pharmaceuticals Source Type: clinical trials
Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older
Condition: Tick-Borne Encephalitis Interventions: Biological: TBE vaccine 0.5 mL; Biological: TBE vaccine 0.25 mL Sponsor: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 1, 2020 Category: Research Source Type: clinical trials
